| Authors: |
Levy C; Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.; Division of Digestive Health and Liver Diseases, University of Miami School of Medicine, Miami, Florida, USA., Jones DEJ; Department of Medical Sciences, NIHR Newcastle Biomedical Research Centre, Newcastle, UK., Mayo MJ; Division of Digestive and Liver Diseases, University of Texas SW Medical Center, Dallas, Texas, USA., Bowlus CL; Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, Sacramento, California, USA., Kowdley KV; Liver Institute Northwest, Seattle, WA, USA., Hirschfield GM; The Autoimmune and Rare Liver Disease Programme, Toronto General Hospital, Toronto, Ontario, Canada., Liu J; Gilead Sciences, Inc., Foster City, California, USA., Burk C; Gilead Sciences, Inc., Foster City, California, USA., Carroll S; Gilead Sciences, Inc., Foster City, California, USA., Crittenden DB; Gilead Sciences, Inc., Foster City, California, USA., Kremer AE; Department of Gastroenterology and Hepatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland. |
